NCT05533372View on ClinicalTrials.gov

MAD Study of IA-14069

PHASE1RecruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

February 28, 2026

Conditions
HealthyRheumatoid Arthritis
Interventions
DRUG

IA-14069

IA-14069 for oral administration.

DRUG

Placebo

Placebo for oral administration.

DRUG

Methotrexate

Methotrexate for oral or SC administration.

DRUG

Methotrexate

Methotrexate for oral administration.

Trial Locations (1)

66219

RECRUITING

ICON plc., Lenexa

All Listed Sponsors
lead

ILAb Co., Ltd.

INDUSTRY